pharmaphorum

SEPTEMBER 10, 2020

Two UK biotechs – Destiny Pharma and Sporegen – have joined forces to develop a nasal spray that they say could serve as a first line of defense against coronavirus infections. The nasal spray could provide protection from infection within a few days of administration, and would be easy to make in bulk at a low cost, say the partners. The programme is still in the early stages of development, but if it works in trials would provide another approach to prevent transmission of SARS-CoV-2, the viru

Vaccines 131

Vaccines Adverse Reactions Immunity Immunization 131

Pharma Times

SEPTEMBER 9, 2020

The drug's cost-effectiveness estimate when used in the maintenance setting is uncertain, the Institute has concluded

125

125

Outsourcing Pharma

SEPTEMBER 8, 2020

The company has submitted an investigational new drug application for FSD201, a possible therapy for patients with severe cases of the virus.

132

132

NY Times

SEPTEMBER 5, 2020

An experimental medication that increases height in children with the most common form of dwarfism has raised hope that it can help them lead easier lives. But some say the condition is not a problem in need of a cure.

83

83

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

SEPTEMBER 8, 2020

An EU consumer body has urged the European Commission to keep compensation measures in place for people who might be harmed in COVID-19 vaccine trials, responding to reports that the drug industry is lobbying to reduce liability. In a letter to the Commissioner for Health and Food Safety Stella Kyriakides, the BEUC says that even though the need for a coronavirus vaccine is urgent, access “must go hand in hand with adequate consumer compensation in case of harm.”.

Vaccines 117

Vaccines Pharmaceutical Companies Pharmaceutical Companies 117

Pharma Times

SEPTEMBER 10, 2020

The proposed deal covers the initial supply of 200 million doses and an option to purchase an additional 100 million, with deliveries starting by the end of 2020, if the vaccine is approved

Vaccines 96

Vaccines 96

Eye on FDA

SEPTEMBER 10, 2020

Vaccines for COVID-19 are the focus of the moment – politically and scientifically speaking. On the political front, there has not only been jockeying to try to squeeze the square peg of a vaccine development timeline into a round hole of political convenience, there is also skepticism expressed by a wary public that the process has become politicized – an unfortunate impression to be sure.

Communication 82

Communication Vaccines Immunity Immunization 82

pharmaphorum

SEPTEMBER 11, 2020

Brent Saunders has been out of the limelight for a few months since departing Allergan after its takeover by AbbVie, but now he is back in a leading role at Vesper Healthcare Acquisition, set up to acquire assets in the healthcare sector. Delaware-incorporated Vesper has filed a with a $400 million initial public offering (IPO) and plans to list on the Nasdaq under the symbol VSRU, with Goldman Sachs and JP Morgan acting as bookrunners.

116

116

Pharma Times

SEPTEMBER 9, 2020

2020's competitions will uphold the highly-respected judging criteria seen in previous years but with virtual processes enabling entrants to compete for a Pharma award from the comfort of their own homes

80

80

NY Times

SEPTEMBER 8, 2020

The company halted late-stage trials of its coronavirus vaccine because of a serious suspected adverse reaction in a participant.

Adverse Reactions 98

Adverse Reactions Vaccines 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Outsourcing Pharma

SEPTEMBER 10, 2020

The company is delving into clinical research partnerships geared toward saving the lives of soldiers, eventually translating findings to civilian care.

98

98

pharmaphorum

SEPTEMBER 7, 2020

Laura Morrill from ECI Partners looks at why data and technology are the keys to success in pharma services post-COVID. The pharmaceuticals industry has, for some time, been behind the curve when it comes to the adoption of technology. High barriers to entering the sector and high levels of regulation are just two factors that have meant that there has often been an “innovation lag” when it comes to implementing new technologies and embracing technological and digital change in the pharma indust

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Vaccines 103

Pharma Times

SEPTEMBER 11, 2020

The drug's use has, however, been restricted to reversing anticoagulation from apixaban or rivaroxaban in adults with life threatening or uncontrolled bleeding in the gastrointestinal tract

75

75

NY Times

SEPTEMBER 7, 2020

The problem occurs when drug-induced side effects are viewed as a new ailment and treated with yet another drug that can cause still other side effects.

85

85

Outsourcing Pharma

SEPTEMBER 9, 2020

The clinical-stage biotech firm is investigating early efficacy of its Cymerus mesenchymal stem cells for treatment of severe COVID-19 patients.

92

92

pharmaphorum

SEPTEMBER 10, 2020

September is Global Diversity and Inclusion month – David Peacock, managing director of MSD in the UK shares with us his insights on why diversity and inclusion is so important and why it is critical to the future success of the life sciences sector. Taking diversity and inclusion seriously, supported by robust policies and accountability for implementation, creates success for everyone, fostering happy, healthy and invested employees, new ways of thinking and opportunities for growth, learning

93

93

Pharma Times

SEPTEMBER 9, 2020

The move follows a report which found it is not clear that the current programme will be able to drive the progress needed in the timescale available

83

83

NY Times

SEPTEMBER 11, 2020

Los ensayos clínicos de varios tratamientos experimentales muestran nuevos avances y la posibilidad de que la parálisis del trastorno pueda ser frenada.

60

60

Drug Patent Watch

SEPTEMBER 11, 2020

Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…. The post Patent delisted for Astrazeneca Ab drug BYDUREON PEN appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

SEPTEMBER 11, 2020

Health systems in lower-income countries could overtake those in richer countries with AI-enabled technologies, according to a report from Novartis Foundation and Microsoft. Technologies such as mobile phone trading platforms, e-banking, e-commerce, and even blockchain applications have often been adopted more quickly and comprehensively in low- and middle-income countries than in high-income countries, the report found.

Hospitals 92

Hospitals 92

Pharma Times

SEPTEMBER 7, 2020

New analysis shows high-dose, once-daily Enerzair Breezhaler cut asthma exacerbation rates by 21% (moderate or severe) and 31% (severe) versus medium-dose

78

78

NY Times

SEPTEMBER 10, 2020

A group of career scientists at the Food and Drug Administration vowed that their work would continue unimpeded and independent of political influence.

Vaccines 60

Vaccines 60

Drug Patent Watch

SEPTEMBER 11, 2020

Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…. The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

SEPTEMBER 7, 2020

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. Preliminary results published in The Lancet are from a non-randomised phase 1/2 trial of 76 people aged 18-60, which found an antibody response within 21 days and no serious adverse events after 42 days.

Immunity 87

Immunity Immunization Vaccines Hospitals 87

Pharma Times

SEPTEMBER 7, 2020

Treatment naïve patients lived longer without disease progression with the Imbruvica-based regimen than those given a chemotherapy-based one

Chemotherapy 78

Chemotherapy 78

Pharma in Brief

SEPTEMBER 10, 2020

The Federal Court of Appeal ( FCA ) provided updated guidance for resuming hearings starting September 1, 2020 and clarified the effect of the federal Time Limits and Other Periods Act (COVID-19) on timelines for commencing and conducting litigation in the FCA. Both the FCA and the Federal Court confirmed that all Practice Directions, judgments, orders and directions from both courts remain in full force and effect.

52

52

Drug Patent Watch

SEPTEMBER 11, 2020

Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from eight suppliers. There are twenty-three…. The post Patent delisted for Purdue Pharma drug OXYCONTIN appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

SEPTEMBER 9, 2020

Geneticist Dr Charles Steward has spent his career studying the human genome – but his work became much more personal when his children were diagnosed with severe neurological diseases. Charlie told pharmaphorum how his search for a genetic cause has led him to straddle the divide between scientist and patient advocate. For some people, a job is more than just a job.

Hospitals 83

Hospitals 83

Pharma Times

SEPTEMBER 11, 2020

The blood test reliably picks up mutations in breast cancer and matches women to different targeted treatments, researchers said

79

79

Drug Channels

SEPTEMBER 10, 2020

Today’s guest post comes from George Keefe, Senior Vice President of External Affairs and Public Policy at Teva Pharmaceuticals. George examines the economic impact of generic pharmaceuticals on the U.S. economy. He argues that the generics industry provides safe, effective, and affordable medicines for many Americans. To learn more, download the Teva United States Economic Impact Report.

Generic Medicine 52

Generic Medicine 52

Drug Patent Watch

SEPTEMBER 11, 2020

Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are nine patents…. The post Patent delisted for Boehringer Ingelheim drug TRADJENTA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

SEPTEMBER 8, 2020

Sandoz’s Pierre Bourdage looks at the unexpected secondary impacts of COVID-19 on countries and healthcare systems, and asks how pharma can help improve sustainability to tackle them. It is undeniable that the COVID-19 pandemic has had a tremendous impact on all aspects of our lives, with ripple effects continuing to evolve. Faced with constant and overwhelming information about the pandemic, including rapidly changing policy responses, there is also an alarming acceleration of a healthcare sust

Biosimilars 74

Biosimilars Drug Pricing Chemotherapy Vaccines 74

Pharma Times

SEPTEMBER 11, 2020

The projects are investigating different aspects of virus transmission in the hope that findings will better inform policy decisions on prevention and containment

67

67

Pharma Mirror

SEPTEMBER 10, 2020

There is an ongoing pandemic that has been proven to harm and even kill many people. Researchers have found that the elderly are particularly susceptible to the COVID-19 virus that caused the epidemic. This is because they often have weaker immune systems, so they can’t fight off a viral infection easily. This new situation puts. The post How Can Nursing Homes Protect Themselves from COVID-19?

Nursing Homes 52

Nursing Homes Immunity Immunization 52

Drug Patent Watch

SEPTEMBER 11, 2020

Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…. The post Patent delisted for Boehringer Ingelheim drug JENTADUETO appeared first on DrugPatentWatch - Make Better Decisions.

52

52